Volunteers injecting experimental vaccine Covivac. Photo: General Writing Domestic vaccines can reach 20-30 million doses/year According to the Ministry of Health, so far, the country has two manufacturers researching and developing vaccines against Covid-19.
The Nanocovax vaccine of the Nanogen Pharmaceutical Biotechnology Joint Stock Company has been approved for a phase 3 clinical trial (TNLS). In the past few days, the Military Medical Academy has administered experimental injections to volunteers aged 18.
According to the research outline, phase 3 will test on about 13,000 volunteers in many provinces and cities such as Hanoi, Hung Yen, Long An, Tien Giang, etc. In the North, the Military Medical Academy will act as the focal point for deployment. at Military Medical Hospital 103 and Hung Yen province’s preventive health center deployed locally. The southern area will be professionally handled by the Pasteur Institute in Ho Chi Minh City, in collaboration with the preventive health centers of Long An and Tien Giang provinces.
At the Military Medical Academy, there are currently more than 6,000 volunteers registered to participate in the trial, of which more than 600 people have been screened and are eligible to participate. In the immediate future, in the first phase of the TNLS phase 3, the Military Medical Academy will test 1,000 people. According to the Military Medical Academy, before that, in stages 1 and 2 of the Nano Covax vaccine trial, 100% of people who injected immunity were protected against the attack of the SARS-CoV-2 virus.
In the phase 3 trial, the Nano Covax vaccine was administered to volunteers from 18 years of age, and there was no maximum age limit for the trial participants. Currently, the oldest person to register for TNLS injection phase 3 is 83 years old. Nano Covax vaccine will also be administered to volunteers with chronic diseases such as hypertension, diabetes (stable disease, do not inject during acute phase) to evaluate the results of immunogenicity. fluid, post-injection reaction… The results of the phase 3 clinical trial are the basis for the Ministry of Health to grant emergency permits and widely inject people to prevent the Covid-19 epidemic, which is expected in the fourth quarter of this year. Earlier, during a working visit to the Military Medical Academy, National Assembly Chairman Vuong Dinh Hue asked the Military Medical Academy to continue to closely coordinate with relevant ministries and sectors to urgently accelerate the implementation of clinical trials. Preparing phase 3 of Nanocovax vaccine, striving for early results to have a preventive vaccine for the community. However, when manufacturing, vaccines must ensure superiority in antibody generation time, with the shortest number of days; minimize side effects to a minimum, especially for people with weak health and underlying diseases; at the same time, must be able to resist and destroy future mutations. In addition, the COVIVAC vaccine of the Nha Trang Institute of Vaccines and Biologicals, is currently in the first phase of the TNLS and is about to be transferred to the second phase of research in Thai Binh.
According to the Ministry of Health, the COVIVAC vaccine is expected to produce about 6 million doses per year and can increase capacity when invested. Meanwhile, with the Nanocovax vaccine, which is expected to produce about 20-30 million doses per year, Nanogen Pharmaceutical Biotechnology Joint Stock Company can increase its capacity when invested.
A vaccine is coming soon that only requires one dose
Information from the Department of Science and Technology (Ministry of Health), a Vietnamese enterprise has discussed and negotiated with the US manufacturer on conditions for transferring technology to produce Covid-19 vaccine from mRNA essence. It is known that this vaccine only needs to be injected with a single dose of 5 mg, has high protection (based on the results of TNLS phase 1, 2), has a storage temperature of 20 – 80 degrees Celsius, currently the vaccine has been tested. end of trial phase 1, 2).
The first factory following the manufacturer’s technology standards will increase the capacity of 100-200 million doses/year, and is expected to start production from the end of 2021 or the first quarter of 2022. In addition, the No. 1 Vaccine and Biological Products Company Limited (VABIOTECH) is also negotiating with a Japanese partner to receive the transfer of vaccine production technology to Vietnam. In addition, VABIOTECH signed an agreement with the Direct Investment Fund of the Russian Federation on the closure of Sputnik-V Covid-19 vaccine tubes from semi-finished products with a scale of 5 million doses/month starting from July 2021. , towards transferring production technology with the scale of 100 million doses/year.
According to Minister of Health Nguyen Thanh Long, vaccines are an important weapon to bring life back to normal. Therefore, the Politburo has a policy on import, research, production and technology transfer for vaccines. Along with creating maximum conditions and quickly solving procedures for businesses and localities to import vaccines, Vietnam also promotes research and domestic production of vaccines. Vietnam is one of the first four countries in the world to isolate the SARS-CoV-2 virus, paving the way for research and production of vaccines, and many positive prospects for people to soon receive domestic vaccines. In addition, the Ministry of Health has worked with many foreign partners, negotiated to buy vaccine copyrights, transfer technology so that Vietnam can get the vaccine as soon as possible and be independent in the source of vaccines used in the country.
Recently, the Ministry of Health has negotiated with Johnson & Johnson Corporation with the hope that this unit will transfer technology to set up a vaccine factory in Vietnam. According to Minister Nguyen Thanh Long, many large corporations in Vietnam want to participate in the global vaccine supply chain. Vietnam is also one of more than 40 countries that can produce vaccines for the vaccination needs of the people, so the vaccine production experience of Vietnamese factories is guaranteed. Vietnam’s national vaccine management system (NRA) has also been certified as meeting standards by the World Health Organization (WHO). Johnson & Johnson’s side commits that after working with the Ministry of Health, it will make efforts to implement solutions to speed up the supply process through the COVAX mechanism, so that Vietnam can have Johnson & Johnson’s vaccine as soon as possible. However, Minister Nguyen Thanh Long also said that, to ensure vaccine security, one of the very important issues is to ensure a sustainable financial source for vaccines. Therefore, the Minister wishes that the community, authorities and businesses continue to support the Vaccine Fund. Vietnam has self-produced many vaccines and put them into the expanded vaccination program, contributing to the eradication and repelling of many dangerous diseases. This is the premise for the successful production of a Covid-19 vaccine. In fact, the research and production of vaccines against Covid-19 faces many difficulties and challenges, but this is the inevitable path we must go if we want to actively supply vaccines to serve the people. Over the past time, the Ministry of Health and State management agencies have created all conditions for administrative procedures for units to conduct vaccine production in the most favorable way. We can fully expect a “made in Vietnam” vaccine because at the moment, everything is going well.

Senior Advisor of the Center for Emergency Response to Public Health Events, Assoc. Tran Dac Phu The success of a vaccine depends not only on the manufacturer, researcher, and manager, but also on the social community. Therefore, we call for the cooperation of society, all people with the health sector to have a clinical trial research program, first of all, to be safe and effective to have a product soon. vaccines produced by Vietnam for the community.

Deputy Director of the Department of Science, Technology and Investment (Ministry of Health), Dr. Nguyen Ngo Quang

According to Lieutenant Colonel, Associate Professor, Assoc. Prof. Dr. Chu Van Men, Director of the Center for Clinical Trials and Bioequivalence, Military Medical Academy, phase 3 injected the Nano Covax vaccine to 13,000 people and administered only a single dose group injection. at least 25 mcg and the placebo injection group. Specifically, according to the protocol approved by the Ministry of Health, the first 1,000 trial injectors of the first phase of phase 3, the volunteers are injected with the ratio of “6 people vaccinated, 1 person injected placebo”. The remaining 12,000 people injected according to the ratio “2 people vaccinated, 1 person injected placebo”. It is expected that the first phase of phase 3 will be conducted by the Military Medical Academy and the Pasteur Institute in Ho Chi Minh City with 1,000 volunteers, each with 500 people. Vietnam’s first COVID-19 vaccine tested in phase 3 on humans. Regarding the reason for choosing the dose group of 25 mcg, Assoc. Prof. Dr. Chu Van Men said that testing at 3 dose levels of 25-50-75 mcg showed that the vaccine was safe on volunteers, capable of generating immunity in 3 doses. There was no difference in dose groups. Therefore, the National Ethical Council in Biomedical Research, Ministry of Health decided to only inject 1 optimal dose of 25 mcg at this stage. Phase 3 is implemented in many centers in the country: The North is deployed by the Military Medical Academy as the focal point at Military Medical Hospital 103, in collaboration with the Preventive Medicine Center of Hung Yen province to deploy locally; In the South, the Ho Chi Minh City Pasteur Institute is the focal point to deploy, in collaboration with the Preventive Medicine Centers of Long An and Tien Giang provinces to deploy locally. After the phase 1 and phase 2 trials, the Nano Covax vaccine is judged to be quite safe, so the criteria for recruiting volunteers will be relaxed more than the previous two phases. 13,000 volunteers participating in phase 3, aged 18-75 years old, only need to check their blood count and check for antibodies to the SARS-CoV-2 virus. People who have been exposed to the SARS-CoV-2 virus or already have antibodies will be excluded from the test population. As of June 11, more than 6,500 volunteers have registered to test the Nano Covax vaccine against COVID-19 phase 3. Senior Colonel, Assoc. Prof. Dr. Ho Anh Son, Deputy Director of the Military Medical and Pharmaceutical Research Institute, Military Medical Academy added: “It is expected that by mid-September 2021, after about 42 days of the second injection. In two of the first 1,000 experimental injections, we will summarize the results of the quality assessment to report. If it is favorable, we will submit the dossier and propose the Government, the Ministry of Health, and the National Ethical Council in the study. In parallel with that process, the unit will continue to test the Nano Covax vaccine on 12,000 volunteers to continue to control the experimental injection and evaluate the effectiveness. protective power of vaccines”. During the testing process and after the antibody sample is available, the Military Medical Academy will coordinate with the Nanogen Pharmaceutical Biotechnology Joint Stock Company, the testing units to conduct the assessment of the ability to neutralize the SARS-CoV virus. -2 in the laboratory for existing virus strains to determine the development direction of vaccine research in the coming period. Through discussions with the expert group of Nanogen Pharmaceutical Biotechnology Joint Stock Company, in addition to recombinant protein technology, there are other technologies for research and production of vaccines. Nanogen as well as many Vietnamese scientists are very interested in mRNA technology – which has been of great interest to the world in recent years. This technology has the advantage of reacting very quickly to the disease, quickly getting a vaccine. According to available information, vaccines produced by this technology are very safe for human use. More information about the phase 3 trial, Lieutenant General, Prof. Dr. Do Quyet, Director of the Military Medical Academy, said that this trial phase is designed according to the adaptive design method, continuing to inject the experimental vaccine. trial and placebo group; health assessment at the time of the first injection, the second dose (done on the 28th day), the 35th day and the 42nd day after injection. The Director of the Military Medical Academy expressed confidence in the safety of the Nano Covax vaccine with the results achieved through the previous two testing phases. Specifically, the concentration of SARS-CoV-2 virus antibodies after the phase 2 trial injection showed that the antibody titre increased very high, from tens to hundreds of times. After the second injection, the volunteers had a physical examination (blood test, blood pressure measurement…) once a week to assess the amount of antibodies appearing in the body; then continue to be monitored for 6 months to get information, assess health as well as immunity ability. Up to now, 100% of volunteers who have been vaccinated with Nano Covax vaccine have produced antibodies in the blood. – Phase I (December 2020), the COVID-19 vaccine Nano Covax was administered to 60 volunteers. – Phase II (February 2021) injected over 554 people. From phase 2, the trial was conducted both at the Military Medical Academy and the Medical Center of Ben Luc district – Long An province (by the Pasteur Institute in Ho Chi Minh City).

Illustration. At the meeting of the National Steering Committee for COVID-19 prevention and control on the afternoon of June 11, Deputy Minister of Health Tran Van Thuan informed that the Ministry of Health had officially approved the phase 3 clinical trial of the vaccine. Vietnam’s first COVID-19 room named Nano Covax. According to Deputy Minister Tran Van Thuan, the Ministry of Health has just approved the phase 3 clinical trial of Nano Covax vaccine of Nanogen Company. According to Lieutenant Colonel, Assoc. Dr. Chu Van Men – Director of the Center for Clinical Trials and Bioequivalence, Military Medical Academy, Ministry of National Defense, phase 3 injected the Nano Covax vaccine to 13,000 people and injected only a single dose group. 25 mcg and placebo injection group (with a ratio of “6 people vaccinated to 1 person injecting placebo” according to the design approved by the Ministry of Health). As for the reason for choosing the 25 mcg dose group, Assoc. Prof. Dr. Chu Van Men said that when the phase 2 trial showed that, the 3 dose levels of 25-50-75 mcg had equivalent safety and immunogenicity. undifferentiated. Therefore, in order to ensure the safety and increase the effectiveness of the number of doses of vaccine production, the National Ethical Council in Biomedical Research, the Ministry of Health decided to inject only 1 optimal dose of 25 mcg at the initial stage. this. Minister of Health Nguyen Thanh Long and Minister of National Defense Phan Van Giang asked and encouraged volunteers to test the vaccine against COVID-19 Nano Covax. Photo: PV. On June 11, the Military Medical Academy said that this unit has started to deploy the phase 3 trial injection of the COVID-19 Nano Covax vaccine for the first 19 volunteers. On the day of injection for 200 people, divided into 2 groups. Accordingly, one group injected the Nano Covax vaccine with a dose of 25mcg, the other group injected a placebo with aluminum excipients. Military medical students will inject 1,000 volunteers in the first time. According to the research outline, phase 3 will test on about 13,000 volunteers in many provinces such as Hanoi, Hung Yen, Long An, Tien Giang… At the Military Medical Academy, there are currently more than 7,000 volunteers registered to participate in the trial, of which more than 600 people have been screened and are eligible to participate. Besides, IVAC’s Covivac vaccine is also preparing to complete phase 1 trial and enter phase 2 in July 2021. Regarding the subjects of vaccination, according to Deputy Minister Tran Van Thuan, in addition to the priority subjects for COVID-19 vaccination under Resolution 21, the Ministry of Health has added workers in industrial zones and will propose more subjects working in establishments dealing in essential goods.

National Assembly Chairman Vuong Dinh Hue visits the vaccine research and production laboratory of the Military Medical Academy – Photo: Thanh Chung A representative of the Military Medical Academy said that it has successfully researched and manufactured a test kit to detect the new strain of corona virus (SARS-CoV-2) by real-time RT-PCR method, used at more than 100 facilities. healthcare throughout the country and exported to 18 countries around the world. Continuing to research and successfully manufacture Amphabio PCR test kits with the ability to test quickly and in large quantities at the same time, which is currently being used effectively in Bac Giang province. Notably, the Academy has been trusted by the Ministry of Health to carry out phase 1 and 2 clinical trials for the Nano Covax vaccine against Covid-19 (from December 2020) and both are generating antibodies. It is expected that from June 2021, there will be a phase 3 clinical trial, deploying over 13,000 volunteers 18 years of age or older. In addition, the Academy has mobilized staff to support the prevention and control of Covid-19 in Quang Nam, Bac Giang, Bac Ninh and Laos. National Assembly Chairman Vuong Dinh Hue visited and worked at the Military Medical Academy – Photo: Thanh Chung Speaking at the meeting, National Assembly Chairman Vuong Dinh Hue highly appreciated the efforts and achievements that the Military Medical Academy has achieved during 72 years of construction and growth, which has received the most noble achievements of the Party. , state and military. In particular, in the prevention and control of the Covid-19 epidemic, the Military Medical Academy is one of the active, active and effective participating units. National Assembly Chairman Vuong Dinh Hue said that in the current period, the task of effective disease prevention is the focus in the implementation of “dual duty”, so vaccines are an important “weapon”, strategic, decisive issues to end and conquer disease. “The XIII Congress of the Party has set a key task of focusing on controlling the Covid-19 pandemic, mass vaccination of the community with Covid-19 vaccine. Therefore, the Military Medical Academy closely coordinates with other agencies. Relevant ministries and sectors urgently speed up the phase 3 clinical trial of the Nano Covax vaccine against Covid-19, striving for early results to have a preventive vaccine for the community” – National Assembly Chairman assigned. The National Assembly Chairman also suggested that the Military Medical Academy should identify challenges such as, there are many domestic and foreign facilities focusing on research and production of vaccines. Mr. Vuong Dinh Hue analyzed that if there is no superior vaccine in terms of quality, price and supply quantity, it will fall into an opportunity trap. A number of vaccine products have been born and put into circulation in countries, along with rigorous testing by the health systems of countries, approved by WHO. However, there is currently a vaccine that has shown its effectiveness compared to the new variant; There are scenarios of monopolistic production, imposing price and quantity, but also opportunities for technology transfer in the direction of humane sharing. “So, the Military Medical Academy to research and produce vaccines, it is necessary to have the shortest time of antibodies, the shortest number of days, the better. The side effects must be minimized, especially for people with underlying diseases. and weak health. Having the ability to resist and adapt to new variants of the virus,” suggested the National Assembly Chairman. At the meeting, the Military Medical Academy proposed to allow the Academy to organize the implementation of the project “Research and Development Center for Human Infectious Diseases” which was approved by the Prime Minister at the government office. Document No. 164 dated December 31, 2020 of the Government Office, which is expected to have a number of functions and tasks such as research on pathogens, development and production of biological products for detection, diagnosis and treatment of diseases. treating infectious diseases, especially dangerous and extremely dangerous diseases, contributing to protecting the health of soldiers and people, especially in emergency and disaster situations. Researching foundational technologies in development, technology transfer and production of vaccines against infectious diseases, especially dangerous and dangerous infectious diseases. Agreeing with the proposal of the Military Medical Academy, National Assembly Chairwoman Vuong Dinh Hue suggested, the Academy needs a state-level scientific research program and emergency approval to research and test. production of vaccines for human infectious diseases. The Ministry of National Defense shall assume the prime responsibility for, and coordinate with relevant agencies in, facilitating and directing the Military Medical Academy to accelerate the implementation of the project “Research and development center for human infectious diseases vaccines” under the theme of: Government policy. Also this afternoon, National Assembly Chairman Vuong Dinh Hue visited the vaccine research and production laboratory at the Military Medicine Research Center building, under the Military Medical Academy. The National Assembly Chairman graciously encouraged the forces directly involved in research, production and volunteers to test the Covid-19 vaccine.

In this phase 3, Nano Covax vaccine will be tested in multi-centers at domestic facilities with the deployment of vaccination for 13,000 volunteers. Specifically, in the North, experimental injections were carried out at the Military Medical Academy (Hanoi) and in Hung Yen province; The southern area is carried out by the Pasteur Institute in Ho Chi Minh City, and is planned to be injected in 2 provinces: Long An and Tien Giang. In the immediate future, in phase 3, 1,000 registered volunteers will be tested, and then continue to recruit more. In this phase 3, there is also research and evaluation of the effect of the vaccine against the variant of the SARS-CoV-2 virus found for the first time in India. By the end of September 2021, after the phase 3 trial is completed, depending on the test results and epidemic developments, the vaccine will be considered for approval for emergency use on a large scale in our country. Step 1: Visit https://www.bluezone.gov.vn or download directly at App Store or CH Play. Step 2: Once downloaded, the application will ask for permission to use Bluetooth to record contact with other Bluezone installed users. If Bluetooth is not open, drag the status bar and turn on Bluetooth; or go to Settings, select Bluetooth and turn it on. Step 3: Once the installation is done, click Scan Around. If someone near you less than 2m has used Bluezone, the application will automatically identify these users and put them in the contact list.

Illustration GS. Dr. Truong Viet Dung, Chairman of the National Ethics Council in Biomedical Research, said in the SK & DS newspaper, in phase 3, the subjects of the Nano Covax vaccine trial in Vietnam will expand. The object here means the area, which can be extended to other areas such as workers in industrial zones. However, areas or industrial zones with COVID-19 cases were not selected for clinical trials because it would be interpreted as the epidemic situation that made people too worried and accepted to participate in the research. Therefore, research can only be carried out in industrial zones at risk of disease outbreaks, not in industrial zones with epidemics. Testing participants for COVID-19 to confirm the absence of antibodies is required. In the spirit of “testing as quickly as possible” of the Government, the Ministry of Health assigned testing units. Fast does not mean cutting, skipping stages. Any stage must comply with international requirements and standards. Do it very quickly but must be very standard, giving it to the Council must be approved immediately. In general, in accordance with the process and step by step of each phase, so that the Ministry of Health has enough scientific basis to be able to grant urgent and conditional use of Nano Covax vaccine in Vietnam. Information on Vietnam plus, Deputy Director of Military Medical Research Institute Ho Anh Son said that according to the latest information, it is possible that as soon as next week (expected in early June 2021) will enter vaccine research. Nano Covax phase 3 with the expected number of volunteers to participate is about 13,000 people. In phase 3, the implementation is very fast, following the correct process, and at the same time meeting the needs of disease control in Vietnam. Up to now, the Military Medical Academy has mobilized a lot of doctors, technicians, students… to participate in the testing process so that it can be ready for deployment in 10 provinces/cities across the country at the same time. country. After testing phase 1 and phase 2, Nano Covax vaccine is quite safe, so the criteria for recruiting volunteers will be relaxed more than the previous 2 phases. Volunteers participating in phase 3 from 18-75 years old, only need to check the blood count and check for antibodies to the SARS-CoV-2 virus. People who have been exposed to the SARS-CoV-2 virus or already have antibodies will be excluded from the test population. More about the phase 3 trial, Lieutenant General, Professor-Dr. Do Quyet, Director of the Military Medical Academy, Ministry of National Defense said that he believes in the safety of the Nano Covax vaccine with the results achieved. through the previous two phases of testing. According to the Director of the Military Medical Academy, immunogenicity is reflected in two main factors: antibody concentration and antibody immunogenicity. Specifically, the concentration of SARS-CoV-2 virus antibodies after injection of the phase 2 trial showed a very high increase in antibody titres, from tens to hundreds of times. Antibody immunogenicity to assess the ability to neutralize SARS-CoV-2 virus living at the 35th day of good response, above the prescribed threshold. As for the ability to neutralize the virus at day 42, the team has now evaluated 22/110 samples; expected to be completed in early June 2021 to report to the National Ethics Council in Biomedical Research. Phase 3 aims to evaluate the protective effect of the vaccine on the community, designed in many centers, expanding to other localities with a larger number of samples with only 1 injection. Based on the results of the evaluation, the National Ethical Council in Biomedical Research selected the experimental injection of 25mcg dose. Strictly following international guidelines, the National Ethical Council for Biomedical Research also identified a phase 3 trial in 10,000 people. Military Medical Academy complies with the approved outline and deploys to recruit volunteers.

The large-capacity “field” Covid-19 laboratory at the Bac Giang Center for Disease Control has been fully installed with the cooperation and transfer support of the Military Medical Academy (Hanoi). This area has an area of ​​​​about 200 m2 and was built quickly in 3 days. The center consists of 8 specialized rooms. In which, 2 laboratories meet biosafety level 2. The most dangerous room is the initial sample processing room. This is the workplace of many officers from the Military Medical Academy, Bac Giang Center for Disease Control and volunteer technicians. Responsible for operating the laboratory is Lieutenant Colonel, Dr. BS Ho Huu Tho (Head of Department of Gene Technology and Cell Genetics, Military Medical Academy). According to Dr. Tho, the special feature of this laboratory is that the SARS-CoV-2 virus detection process is highly sensitive, with the cost savings being reduced by nearly half compared to traditional methods. At the same time, the center has the capacity to test tens of thousands of people every day. According to Dr. Tho, this is the world’s first gene technology, using artificial intelligence to analyze PCR results to detect SARS-CoV-2 pathogens (known as AIMS RT-PCR technology). The sensitivity of this method was evaluated against an in vitro RNA standard set for a detection threshold of 7.2 copies/reaction, nearly 7 times lower than the WHO recommended procedure, when evaluating under the same experimental conditions (50 copies/reaction). This study was clinically evaluated on 142 positive cases, 1,034 negative cases for SARS-CoV-2 and 14 other respiratory viruses. The sensitivity and specificity of the method were both 100%. More importantly, the procedure was successful in mixing 100 patient samples in a single real-time reaction without compromising sensitivity. As such, this is a simple, super-sensitive and potential test method for large-scale screening of SARS-CoV-2 with cost savings many times over. According to Dr. Tho, this method is like a weapon we switch from a defensive state to an attack against the Covid-19 epidemic. To communicate with the staff working in the lab, the commander had to use a walkie-talkie system because the windows were always foggy because of the mist and Chloramin B disinfectant. Besides, the technician was wearing clothes For protection, entering the lab will be called by the number corresponding to the job they are undertaking. After each opening to receive samples, the room is sprayed with disinfectant to avoid the risk of infection. All generated waste is also collected and treated according to regulations of the Ministry of Health. To maintain testing capacity, nearly 100 cadets of the Military Medical Academy are divided into small teams working for 8 hours, with 3 rotating teams each day to ensure that the laboratory is always open 24 hours a day. Tran Hoang Minh (student of Military Medical Academy) and friends relax before the shift. He is in charge of the work of separating and taking samples, so the risk of infection is very high. However, Minh feels proud to work at this center. “The laboratory capable of large-scale testing is a very powerful weapon in the fight against the epidemic. With mobilized human strength, strong weapons and high determination, I believe the epidemic will be quickly controlled.” male students share.

At the same time, the grant helps to urgently invest in the production system of materials and equipment to ensure the supply of a sufficient number of necessary vaccines, supplemented with the amount of imported vaccines, towards the completion of the Covid-19 vaccination program. -19 for the people of Vietnam right this year. Test injection of Nanocovax vaccine phase 1 at the Military Medical Academy. Photo: Viet Linh. In phase 3, the Nanocovax vaccine will be tested in multi-centers at domestic facilities with about 13,000 volunteers. In the North, there are Military Medical Academy and Hung Yen, in the South, there are Pasteur Institutes in Ho Chi Minh City and Long An. Phase 3 is divided into several sub-phases, first injecting 800 registered volunteers, then continuing to recruit more. The optimal dose chosen for phase 3 is 25 mcg. Through the study, all 3 dose groups of 25 mcg, 50 mcg and 75 mcg produced equivalent immunity, due to the equal effectiveness, the Ethics Committee chose the lowest dose for production, saving raw materials. If all goes well, by the end of September, phase 3 testing will be complete. At that time, Vietnam can produce the first Covid-19 vaccine. Exchange with Zing Mr. Ho Nhan, founder and general director of Nanogen Company, did not comment or disclose more about this information. He said the company has stocked up enough materials to produce a vaccine right after the third phase of testing is completed. The company said that if it goes well, it can produce 100 million doses this year. Nanocovax vaccine is Vietnam’s first Covid-19 vaccine that is allowed to be tested in clinical trials, manufactured by Nanogen Company based on recombinant protein technology. The phase 1 clinical trial took place from December 17, 2020, to the end of April completed the phase 2 trial on 560 volunteers, expanding the audience from 18 to over 60 years old, of which one the number of people with underlying diseases such as hypertension, dyslipidemia, diabetes, grade 1 cardiovascular disease… are not too severe. Besides Nanocovax, the second domestic vaccine being tested is Covivac of IVAC Company, which has now completed phase 1 injection.

On May 12, at the Ministry of Health, Prof. Dr. Tran Van Thuan, Deputy Minister of Health, received 10,000 tests for SARS-CoV-2 test for epidemic prevention and control, awarded by Ampharco USA Pharmaceutical Joint Stock Company. donate. Facing the complicated situation of the Covid-19 epidemic from the end of April 2021 until now, Vietnam has recorded many domestic cases in 26 provinces and cities and hospitals, the Vietnam Young Physicians Association. requested the Ministry of Health to receive 10,000 SARV-COV-2 test kits produced and donated by Amharco USA Pharmaceutical Joint Stock Company, in order to support the strengthening of testing capacity for Covid-19 epidemic prevention and control. Speaking at the reception ceremony, Prof. Dr. Tran Van Thuan, Deputy Minister of Health, welcomed the fact that Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from the Military Medical Academy to research and produce the kit. test “made in Vietnam”. The Deputy Minister said that in the face of the situation that the Covid-19 epidemic continues to affect all aspects of economic and social life, it is very meaningful for Amphaco USA to accompany the health sector to support 10,000 test kits. demonstrating the company’s social responsibility in joining hands to fight the pandemic. This is also the Government’s policy in encouraging scientists to research and produce SARS-CoV-2 diagnostic test products and products, actively contributing to the prevention and control of the Covid-19 epidemic. 19. Le Ngoc Bo – Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product developed by Amphaco USA Pharmaceutical Joint Stock Company. Research and development, according to technology transferred from the Military Medical Academy, can detect most strains of the SARS-CoV-2 virus up to now. This kit has been licensed for circulation by the Ministry of Health in Decision No. 2263/QD-BYT dated May 7, 2021. During the research and production process, the kit has been tested and clinically proven on over 2,000 patient samples. Prof. Dr. Do Quyet, Director of the Military Medical Academy, said that the AmphaBio HT- Hithroughput PCR Covid-19 test kit is a cooperation product between the Military Medical Academy and Ampharco USA, applying new technologies from the United States. . Military Medical Academy always creates the best conditions for its scientists to research and develop products of high and timely application in the prevention and control of the Covid-19 epidemic. In order to ensure the storage conditions of the above 10,000 tests, the Ministry of Health requests the Company to support the storage and preservation of the test numbers that have supported the above epidemic prevention and control at the Company’s storage warehouse. Based on the epidemic situation and proposals of units and localities; The Ministry of Health will make a decision to allocate the above test numbers to medical facilities to serve the prevention and control of the Covid-19 epidemic. Based on the allocation decision of the Ministry of Health, request the company to support the transportation and handover of testing to units and localities in a timely manner according to regulations.

Leaders of the Ministry of Health received 10,000 Covid-19 test kits. Photo: Nguyen Nhien. Facing the complicated situation of the Covid-19 epidemic from the end of April 2021 to the present, Vietnam has recorded many domestic cases in 26 provinces and cities and hospitals, the Vietnam Young Physicians Association. requested the Ministry of Health to receive 10,000 SARV-COV-2 test kits produced and donated by Amharco USA Pharmaceutical Joint Stock Company, in order to support the strengthening of testing capacity for Covid-19 epidemic prevention and control. Speaking at the reception ceremony, Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomed the fact that Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from the Military Medical Academy to research and produce the kit. test “made in Vietnam”. Deputy Minister Tran Van Thuan emphasized that, with the Covid-19 epidemic continuing to affect all aspects of socio-economic life, it is a very worthwhile job for Amharco USA to accompany the health sector to support 10,000 test kits. meaningful, demonstrating the company’s social responsibility in joining hands to fight the pandemic. This is also the Government’s policy in encouraging scientists to research and produce SARS-CoV-2 diagnostic test products and products, actively contributing to the prevention and control of the Covid-19 epidemic. 19. Le Ngoc Bo – Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product invested by Amphaco USA Pharmaceutical Joint Stock Company. , developed according to technology transferred from the Military Medical Academy, can detect most strains of the SARS-CoV-2 virus so far. This kit has been licensed for circulation by the Ministry of Health in Decision No. 2263/QD-BYT dated May 7, 2021. During the research and production process, the kit has been tested and clinically proven on over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists, the partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “fighting the epidemic like fighting the enemy”, contributing to Vietnam’s fight against the Covid-19 epidemic. According to Prof. Dr. Do Quyet – Director of the Military Medical Academy, the AmphaBio HT – Hithroughput PCR Covid-19 test kit is a product of cooperation between the Military Medical Academy and Ampharco USA, applying new US technologies. . Military Medical Academy always creates the best conditions for its scientists to research and develop products of high and timely application in the prevention and control of the Covid-19 epidemic.

Leaders of the Ministry of Health emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of socio-economic life, the fact that Ampharco USA accompanying the Health sector to support 10,000 test kits is a very job. makes sense, demonstrates the company’s social responsibility in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and manufacture products and biologicals for SARS-CoV-2 diagnostic tests, actively contributing to the prevention and control of COVID- 19 ”. The ceremony of giving away 10,000 test kits of COVID-19 “made in Vietnam”. Test kit COVID-19 “AmphaBio HT- Hithroughput PCR COVID-19” is a product invested by Ampharco USA Pharmaceutical Joint Stock Company, research and development, according to technology transferred from Military Medical Academy, yes detected most of the strains of SARS-CoV-2 virus up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. This is the result of more than a year of continuous efforts of the team of scientists and partners of Ampharco USA Pharmaceutical Joint Stock Company to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”. . Director of Military Medical Academy – Lieutenant General, Prof. Dr. Do Quyet assessed that the AmphaBio HT- Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of the United States. Military Medical Academy always creates the best conditions for the academy’s scientists to research and develop highly applied products, to promptly use them effectively in the prevention and control of COVID-19 epidemics. To ensure the preservation conditions of the 10,000 tests mentioned above, the Ministry of Health has also asked the Company to assist with storage and preservation. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test numbers to medical facilities to serve the COVID-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company is requested to assist in transporting and handing over testing to units and localities promptly according to regulations./.

Ministry of Health received 10,000 test tests for SARS-CoV-2. (Photo: PV / Vietnam +) On May 12, the Ministry of Health received 10,000 test tests for SARS-CoV-2 for work epidemic prevention . Facing complicated developments of COVID-19 from the end of April 2021 up to now, Vietnam has recorded many domestic cases in 26 provinces, cities and hospitals. Therefore, the Vietnam Young Physician Association has asked the Ministry of Health to receive 10,000 SARV-COV-2 test kits produced and awarded by Ampharco USA Pharmaceutical Joint Stock Company to support strengthening laboratory capacity. , anti-epidemic COVID-19. Speaking at the Reception Ceremony, Deputy Minister of Health Tran Van Thuan emphasized that the COVID-19 epidemic continues to affect all aspects of socio-economic life, with Ampharco USA accompanying the health sector to support 10,000 The test kit is a very meaningful job, demonstrating the company’s social responsibility in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and manufacture products and biologicals for SARS-CoV-2 diagnostic tests, actively contributing to the prevention and control of COVID- 19. Test kit COVID-19 “AmphaBio HT- Hithroughput PCR COVID-19” is a product invested by Ampharco USA, research and development, according to technology transferred from Military Medical Academy, can detect most Variants of the SARS-CoV-2 virus to date. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. Professor Do Quyet – Director of Military Medical Academy said that the AmphaBio HT- Hithroughput PCR COVID-19 test kit is a cooperation product between Military Medical University and Ampharco USA, applying new US technologies. Military Medical Academy always creates the most optimal conditions for its scientists to research and develop highly timely applied products in the prevention and control work. COVID-19 translation ./.

Deputy Minister of Health Tran Van Thuan received 10,000 test kits for SARS-CoV-2 On May 12, Prof.Dr. Tran Van Thuan, Deputy Minister of Health, has received 10,000 SARS-CoV-2 test kits for epidemic prevention, awarded by Ampharco USA Pharmaceutical Joint Stock Company. Facing the complicated situation of Covid-19 epidemic in the period from the end of April 2021 up to now, Vietnam has recorded many cases in the country in 26 provinces, cities and hospitals, Vietnam Young Physician Association. has proposed to the Ministry of Health to receive 10,000 test kits for SARV-COV-2 produced and awarded by Ampharco USA Pharmaceutical Joint Stock Company to support capacity building for Covid-19 epidemic prevention and control. Speaking at the reception, Prof.Dr. Tran Van Thuan, Deputy Minister of Health emphasized: “In the face of the Covid-19 epidemic continuing to affect all aspects of socio-economic life, the fact that Ampharco USA, together with the health sector, supports 10,000 test kits. a very meaningful job, demonstrating the company’s social responsibility in joining hands to repel the pandemic. This is also a policy of the Government to encourage scientists to research and produce products and biologicals for diagnostic tests for SARS-CoV-2, actively contributing to the prevention and control of Covid- 19 ”. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5. During the research and production process, the kit has been tested and clinically proven over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists and partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”, contributes to Vietnam’s anti-epidemic Covid-19. Prof.Dr. Do Quyet, Director of Military Medical Academy, said that the AmphaBio HT-Hithroughput PCR Covid-19 test kit is a product of cooperation between the Military Medical Academy and Ampharco USA, applying new technologies of the United States. Military Medical Academy always creates the best conditions for its scientists to research and develop highly applied products, to promptly use them effectively in Covid-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health established a Committee for Mobilization and Coordination of Supporting Resources for Covid-19 epidemic prevention and control (Decision No. 1219 / QD-BYT dated 19 / 3/2020 of the Minister of Health). The Ministry of Health agreed to receive 10,000 test kits for SARS-CoV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company. However, in order to ensure the storage conditions of the 10,000 test kits mentioned above, the Ministry of Health requests the company to assist in storing and preserving the test numbers that have supported the prevention of the above epidemic at the public warehouse. ty.

Deputy Minister of Health emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of social and economic life, the Ampharco USA accompanying the Health sector to support 10,000 test kits is a job. It is very meaningful, demonstrating the company’s social responsibility in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and manufacture products and biologicals for SARS-CoV-2 diagnostic tests, actively contributing to the prevention and control of COVID- 19 ”. The AmphaBio HT- Hithroughput PCR COVID-19 kit can detect most of the strains of the SARS-CoV-2 virus to date. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. Professor, Dr. Do Quyet, Director of Military Medical Academy, said that the AmphaBio HT- Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of USA. Military Medical Academy always creates the most optimal conditions for the academy’s scientists to research and develop highly and timely applied products in COVID-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health has established a Committee to advocate and coordinate the COVID-19 epidemic prevention and control support. The Ministry of Health agreed to receive 10,000 test kits for SARS-CoV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company.
However, in order to ensure the storage conditions of the 10,000 test tests mentioned above, the Ministry of Health requested the Company to assist in storing and preserving the above-mentioned kits that supported the prevention of the above epidemic at the preservation warehouse of the Company. ty. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test kits to medical facilities to serve the COVID-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company supports to transport and hand over the testing kit to units and localities promptly according to regulations.

The Ministry of Health received 10,000 Covid-19 test kits to support epidemic prevention and control. Photo: Nguyen Nhien (Office of the Ministry of Health). Faced with complicated developments in the Covid-19 epidemic since the end of April 2021 up to now, Vietnam has recorded many domestic cases in 26 provinces, cities and hospitals. The Vietnam Young Physician Association has asked the Ministry of Health to receive 10,000 SARS-COV-2 test kits produced and awarded by Ampharco USA Pharmaceutical Joint Stock Company, to support strengthening capacity for prevention and control. Covid-19 translation. At the reception, Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomed Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from Military Medical Academy to research and produce the test kit. experience “made in Vietnam”. “In the face of the Covid-19 epidemic that continues to affect all aspects of socio-economic life, the fact that Ampharco USA accompanying the health sector to support 10,000 test kits is a very meaningful job, showing responsibility. Company society in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and produce products and biologicals for diagnostic testing for SARS-COV-2, actively contributing to the prevention and control of Covid- 19 ”- Deputy Minister of Health emphasized. Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company Le Ngoc Bo said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product invested by Ampharco USA Pharmaceutical Joint Stock Company, Research and development, according to technology transferred from the Military Medical Academy, can detect most of the strains of the virus SARS-CoV-2 up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists and partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”, contributes to Vietnam’s anti-epidemic Covid-19. Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomes Ampharco USA Pharmaceutical Joint Stock Company to use technology transferred from Military Medical Academy to research and produce “made in Vietnam” test kit. . Photo: Nguyen Nhien (Office of the Ministry of Health). Prof. Dr. Do Quyet – Director of Military Medical Academy said, AmphaBio HT- Hithroughput PCR Covid-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of the United States. . Military Medical Academy always creates the best conditions for its scientists to research and develop timely and highly applied products in Covid-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health established a Committee for the mobilization and coordination of sources of support for Covid-19 epidemic prevention. The Ministry of Health agreed to receive 10,000 test tests for SARS-COV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company. However, in order to ensure the storage conditions of the 10,000 test tests mentioned above, the Ministry of Health requests that the company assist with the storage and preservation of the test numbers that have supported the prevention of the above epidemic at the public warehouse. ty. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test numbers to medical facilities to serve the Covid-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company is requested to assist in transporting and handing over testing to units and localities promptly according to regulations.

The COVID-19 test kit is researched and developed, according to the technology transferred from the Military Medical Academy, which can detect most of the strains of the SARS-CoV-2 virus up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. Prof.Dr. Tran Van Thuan – Deputy Minister of Health. Photo: Tuan Anh. Speaking at the Reception Ceremony, Prof.Dr. Tran Van Thuan – Deputy Minister of Health welcomed the product “made in Vietnam” and emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of socio-economic life, Ampharco USA’s accompanying Health sector is a very meaningful job, demonstrating the social responsibility in joining hands to repel the epidemic. The Ministry of Health praised the impulsive spirit of the Vietnam Young Physicians Association and believed in the wisdom, gesture and heart of the team of Vietnamese medical doctors, scientists, and the consensus of enterprises, co. For the whole country, Vietnam will defeat COVID-19 ”. The Ministry of Health received 10,000 COVID-19 test kits to support epidemic prevention. Photo: Tuan Anh. Prof.Dr. Do Quyet – Director of Military Medical Academy said, AmphaBio HT-Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of the United States. Military Medical Academy always creates optimal conditions for the academy’s scientists to research and develop timely and highly applied products in COVID-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health has established a Committee for Mobilization and Coordination of the COVID-19 epidemic prevention and control support (Decision No. 1219 / QD-BYT dated 19 / 3/2020 of the Minister of Health). The Ministry of Health agreed to receive 10,000 test tests for SARS-CoV-2 awarded this time. However, to ensure the storage conditions of 10,000 tests mentioned above; The Ministry of Health requested the Company to support the storage and preservation of the test numbers that supported the prevention of the above epidemic in the Company’s repository. Based on the epidemic developments and proposals of units and localities; The Ministry of Health will decide to allocate the above test numbers to medical facilities to serve the COVID-19 epidemic prevention and control. Based on the allocation decision of the Ministry of Health, the Company is requested to assist in transporting and handing over testing to units and localities promptly.

People were tested with Nano Covax vaccine phase 2. In phase 2, the volunteers were divided into 4 groups, including groups of injections with doses of 25mcg, 50mcg, 75mcg and placebo. All 3 doses of 25mcg, 50mcg and 75mcg injected to volunteers were immunogenic, of which the 25mcg dose level is considered to be the most effective. The research team will report the results of phase 2 to the Ministry of Health. It is expected that on April 27, it will submit to the National Bio-Medical Research Ethics Council of the Ministry of Health a plan to deploy the clinical trial injection of Nano Covax vaccine phase 3. According to the plan, Nano Covax vaccine in this phase will be tested in large groups, from 10,000 to 15,000 people, starting from May 5-2021. The research team is expected to propose a single test injection dose of 25 mcg. Previously, as reported by the New Hanoi News, Nano Covax was the first Covid-19 vaccine in Vietnam to be injected for clinical trials in humans, researched and developed by Nanogen Technology Joint Stock Company. In phase 2, there were 560 volunteers registered for the trial, expanding the subjects from 18 to over 60 years old, of which, some people had background diseases such as hypertension, dyslipidemia, diabetes, heart disease. 1 degree circuit … not too heavy. The test vaccination of Covid-19 Nano Covax vaccine phase 2 was held at two bridge points: the Military Medical Academy and the Pasteur Institute of Ho Chi Minh City (participating in the study, conducted in Ben Luc district, province. Long An). For objective reasons, there were 4 people who asked to withdraw from the list of experimental injections. As a result, 556 people completed the second phase of Nano Covax vaccine trial. Step 1: Access to https://www.bluezone.gov.vn or directly download at App Store or Play Store. Step 2: Once downloaded, the app will ask for Bluetooth permission to record contact with other Bluezone installed users. If Bluetooth isn’t open, drag the status notification bar and turn on Bluetooth; Or go to Settings, select Bluetooth and turn it on. Step 3: After the installation is complete, click Scan Around. If someone near you less than 2m has used Bluezone, the application will automatically identify these users and put them on the contact list.

Over the years, the death rate in burn patients has decreased by 5-6% to 1-1.7%. Many of the patients with extensive burns have been saved. Currently, Le Huu Trac National Hospital has saved the life of an adult patient with a superficial burn area of ​​85% of the body area (DTCT), deep burns up to 52% of DTCT, this rate for children is 80% DTCT and 50 % DTCT. More importantly, the number of patients with superficial burn area less than 40% of patients with severe burns and deep burns below 30% previously died very high, so far almost no longer die. Many patients with severe burns with complicated complications such as sepsis, septic shock, respiratory burns, acute kidney failure, gastrointestinal bleeding … have been saved. Head of Department-Center of Plastic and Reconstructive Surgery (National Burn Hospital Le Huu Trac) guides clinical practice for graduate students. Photo: TIEN THANH Along with the spirit of solidarity, unity, dynamism, creativity, daring to think and daring to do of collectives and individuals, is the factor that created the great leaps and developments of National Park Le Huu Trac. From a small and modest initial base, thanks to the effective investment of the Ministry of Health, the Ministry of Defense, the Military Medical Academy and effective local help, Le Huu Trac National Park has had get a spacious and modern appearance. The Party Committee and the Board of Directors of the hospital have led, directed and implemented the implementation of world-wide advanced and modern techniques in burn treatment, plastic surgery and wound healing such as: Technique of using self-skin and homologous skin in combination with two-layer transplant in the treatment of patients with deep and large-area burns; early feeding technique through gastric catheterization; continuous super dialysis technique; micro-surgery techniques in the treatment of burn sequelae; Depth diagnosis technique by Laser Doppler … Also from here, the model, name, organization and staffing of the hospital have also changed and developed to meet the requirements of political tasks. to be delivered in the new period. In addition to emergency, treatment, in training, along with other departments of HVQY, for many years, the hospital has always been interested in building a team of trainers in the Department of Burns and Disaster Medicine and the Department-Center. Plastic and reconstructive surgery; participating in training thousands of long-term students, hundreds of nursing bachelors and primary practitioners of burns, primary and secondary specialists, masters, and doctors in burns, plastic surgery and regenerating together with hundreds of nurses of lower level hospitals; Focusing on self-training, retraining and foreign language training for staff and staff, constantly improving the professional qualifications for physicians and staff. In addition, over the past years, Le Huu Trac National Hospital has completed more than 100 scientific topics, more than 60 technical innovation initiatives in all areas such as: Burn treatment, burn sequelae, plastic surgery. , wound healing, cell technology, skin replacement materials, burn medicine … The results of scientific research are highly practical, widely applied in treatment and training, bringing Significantly effective, helps shorten days of treatment, lower mortality, reduce costs for patients. Many subjects became dissertations of graduate students, master theses, specialized doctors at level 1, level 2. Some projects at hospital level have been upgraded into ministerial- and state-level subjects. The research results of the topics have brought about common effects to the burn specialty of the whole army, nationwide, becoming an achievement of the health sector of the country. In addition, Le Huu Trac National Hospital has always focused on doing well the directing work throughout the country, together with medical facilities, step by step build up a treatment system for burn specialist in provincial and city hospitals. International cooperation with countries with a developed health economy has been strengthened, with many staff members being members of the World Burn Association, the European Burn Association and the Asia-Pacific Burn Association. With qualifications, capabilities and development, the hospital successfully hosted many international burn conferences, sent staff to participate in scientific reports at domestic and international burn conferences, and received by partners. appreciate. Promoting the heroic tradition, on the basis of achievements and lessons learned, in the coming years, the Party Committee, the Board of Directors of the National Park Le Huu Trac determined to thoroughly grasp the above directives and resolutions, raising the high spirits. The spirit of solidarity unanimously agreed, creativity, constantly improving the professional qualifications of the team of physicians, creating all conditions for white-shirted soldiers to study, practice, improve medicine, foster medical ethics, building Le Huu Trac National Hospital to develop in all aspects, worthy of being an exemplary medical center for first aid, burn treatment, plastic surgery, wound healing, training, scientific research, directing, become the reliable fulcrum of the army and people. Over the past years, Le Huu Trac National Park has twice been awarded the title of Hero of the People’s Armed Forces; 1 First Class Independence Medal; 2 Third Class Military Achievement Medal; 2 Victory Medal, First and Second Class; 3 Labor Medal, First, Second, Third and many other noble awards.